IRIS Accounts Production v25.1.0.734 10367545 director 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103675452023-09-30103675452024-09-30103675452023-10-012024-09-30103675452022-09-30103675452022-10-012023-09-30103675452023-09-3010367545ns15:EnglandWales2023-10-012024-09-3010367545ns14:PoundSterling2023-10-012024-09-3010367545ns10:Director12023-10-012024-09-3010367545ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010367545ns10:SmallEntities2023-10-012024-09-3010367545ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010367545ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010367545ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010367545ns10:FullAccounts2023-10-012024-09-3010367545ns10:RegisteredOffice2023-10-012024-09-3010367545ns5:CurrentFinancialInstruments2024-09-3010367545ns5:CurrentFinancialInstruments2023-09-3010367545ns5:Non-currentFinancialInstruments2024-09-3010367545ns5:Non-currentFinancialInstruments2023-09-3010367545ns5:ShareCapital2024-09-3010367545ns5:ShareCapital2023-09-3010367545ns5:RetainedEarningsAccumulatedLosses2024-09-3010367545ns5:RetainedEarningsAccumulatedLosses2023-09-3010367545ns5:PlantMachinery2023-10-012024-09-3010367545ns5:PlantMachinery2023-09-3010367545ns5:PlantMachinery2024-09-3010367545ns5:PlantMachinery2023-09-3010367545ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010367545ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30103675451ns10:Director12023-09-30103675451ns10:Director12022-09-30103675451ns10:Director12023-10-012024-09-30103675451ns10:Director12022-10-012023-09-30103675451ns10:Director12024-09-30103675451ns10:Director12023-09-30
REGISTERED NUMBER: 10367545 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

Asihene Healthcare Limited

Asihene Healthcare Limited (Registered number: 10367545)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Asihene Healthcare Limited

Company Information
for the Year Ended 30 September 2024







DIRECTOR: W K Opare





REGISTERED OFFICE: 50 Portman Road
Wavertree
Liverpool
Merseyside
L15 2HJ





REGISTERED NUMBER: 10367545 (England and Wales)





ACCOUNTANTS: RM Burke & Co
Suite 4 Second Floor
Honeycomb
7 - 15 Edmund Street
Liverpool
Merseyside
L3 9NG

Asihene Healthcare Limited (Registered number: 10367545)

Statement of Financial Position
30 September 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 - 316

CURRENT ASSETS
Debtors 6 27,212 34,079
Cash at bank 242 1,216
27,454 35,295
CREDITORS
Amounts falling due within one year 7 25,508 3,781
NET CURRENT ASSETS 1,946 31,514
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,946

31,830

CREDITORS
Amounts falling due after more than one
year

8

-

31,707
NET ASSETS 1,946 123

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,846 23
SHAREHOLDERS' FUNDS 1,946 123

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Asihene Healthcare Limited (Registered number: 10367545)

Statement of Financial Position - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 May 2025 and were signed by:





W K Opare - Director


Asihene Healthcare Limited (Registered number: 10367545)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Asihene Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

Asihene Healthcare Limited (Registered number: 10367545)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 1,397
DEPRECIATION
At 1 October 2023 1,081
Charge for year 316
At 30 September 2024 1,397
NET BOOK VALUE
At 30 September 2024 -
At 30 September 2023 316

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 27,212 34,079

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 26,715 -
Taxation and social security (1,748 ) 3,420
Other creditors 541 361
25,508 3,781

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans - 31,707

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2024 and 30 September 2023:

2024 2023
£    £   
W K Opare
Balance outstanding at start of year (34,079 ) (34,079 )
Amounts advanced 6,867 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (27,212 ) (34,079 )